Skip to content

Structural Imaging Assisted Retinal Fluorescence Lifetime Imager (STARFLI)

Structural Imaging Assisted Retinal Fluorescence Lifetime Imager (STARFLI) Using a High-speed Fluorescence Lifetime Measurement Scheme

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05819307
Acronym
STARFLI
Enrollment
70
Registered
2023-04-19
Start date
2023-05-01
Completion date
2024-05-01
Last updated
2023-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinal Disease

Brief summary

To investigate the feasibility of a combined OCT/FLIM device

Detailed description

To investigate the feasibility of a combined Optical coherence tomography/ Fluorescence Lifetime Measurement (OCT/FLIM) device.

Interventions

DEVICEOCT/FLIM

OCT/FLIM imaging of the retina

Sponsors

Haag-Streit AG
CollaboratorINDUSTRY
University of Bern
CollaboratorOTHER
Insel Gruppe AG, University Hospital Bern
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 120 Years
Healthy volunteers
Yes

Inclusion criteria

* Subject must be willing to give written informed consent * Age: Patients and Probands 18 years or greater * Both eyes will be assessed in the study

Exclusion criteria

* Patients not willing or able to sign informed consent * Patients younger than 18 years * Patients with epilepsy

Design outcomes

Primary

MeasureTime frameDescription
Feasibility of device1 yearWe will organize and perform an observational study with the prototype OCT+FLIM device and contribute the acquired OCT/FLIM datasets from eyes of different age and status of the crystalline lens.

Secondary

MeasureTime frameDescription
To provide two key technology aspects of the project:1 yearA. The first will be to bring forward a novel registration strategy for calibrated OCT and FLIM modalities, so that these can be used in conjunction. B. The second will be to develop an image calibration and normalization method using the measured lens fluorescence lifetime and possibly also structural (OCT) information on lens and retina, so that data acquired by the device can be used across different patients in a consistent way.

Countries

Switzerland

Contacts

Primary ContactPia Steinger
pia.steinger@insel.ch+41316328546

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026